These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How is stereotactic brain biopsy evolving? A multicentric analysis of a series of 421 cases treated in Rome over the last sixteen years. Callovini GM, Telera S, Sherkat S, Sperduti I, Callovini T, Carapella CM. Clin Neurol Neurosurg; 2018 Nov; 174():101-107. PubMed ID: 30227295 [Abstract] [Full Text] [Related]
3. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients. Wu S, Wang J, Liu W, Hu F, Zhao K, Jiang W, Lei T, Shu K. BMC Neurol; 2021 May 11; 21(1):190. PubMed ID: 33975554 [Abstract] [Full Text] [Related]
4. 5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients. Kiesel B, Millesi M, Woehrer A, Furtner J, Bavand A, Roetzer T, Mischkulnig M, Wolfsberger S, Preusser M, Knosp E, Widhalm G. Neurosurg Focus; 2018 Jun 11; 44(6):E7. PubMed ID: 29852770 [Abstract] [Full Text] [Related]
5. Safety and efficacy of frameless and frame-based intracranial biopsy techniques. Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ. Acta Neurochir (Wien); 2008 Jan 11; 150(1):23-9. PubMed ID: 18172567 [Abstract] [Full Text] [Related]
11. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma. Ouyang T, Wang L, Zhang N, Zhang Z, Xiong Y, Li M, Hong T. World Neurosurg; 2020 Jul 11; 139():e508-e516. PubMed ID: 32311566 [Abstract] [Full Text] [Related]
13. Experience with 102 Frameless Stereotactic Biopsies Using the neuromate Robotic Device. Yasin H, Hoff HJ, Blümcke I, Simon M. World Neurosurg; 2019 Mar 11; 123():e450-e456. PubMed ID: 30500594 [Abstract] [Full Text] [Related]
14. Complications of MRI-guided stereotactic biopsy of brain lymphoma. Malikova H, Liscak R, Latnerova I, Guseynova K, Syrucek M, Pytlik R. Neuro Endocrinol Lett; 2014 Mar 11; 35(7):613-8. PubMed ID: 25617885 [Abstract] [Full Text] [Related]
15. The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients. Shi X, Zhang X, Yi C, Wang X, Chen Z, Zhang B. Clin Nucl Med; 2013 Feb 11; 38(2):98-102. PubMed ID: 23334122 [Abstract] [Full Text] [Related]
16. Diagnostic Yield of Stereotactic Brain Biopsy in a Sub-Saharan Tertiary Center: A Comprehensive 10-Year Retrospective Analysis. Mogere EK, Abdifatah K, Maina B, Nassiuma M, Olunya DLO, Cheserem B, Qureshi M. World Neurosurg; 2024 Apr 11; 184():e689-e694. PubMed ID: 38346588 [Abstract] [Full Text] [Related]
17. Stereotactic biopsy of cerebellar lesions: straight versus oblique frame positioning. Quick-Weller J, Brawanski N, Dinc N, Behmanesh B, Kammerer S, Dubinski D, Seifert V, Marquardt G, Weise L. Br J Neurosurg; 2018 Apr 11; 32(2):210-213. PubMed ID: 29069919 [Abstract] [Full Text] [Related]
19. Surgical Resection for Primary Central Nervous System Lymphoma: A Systematic Review. Labak CM, Holdhoff M, Bettegowda C, Gallia GL, Lim M, Weingart JD, Mukherjee D. World Neurosurg; 2019 Jun 11; 126():e1436-e1448. PubMed ID: 30904794 [Abstract] [Full Text] [Related]
20. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review). Liu Y, Yao Q, Zhang F. Int J Oncol; 2021 Mar 11; 58(3):371-387. PubMed ID: 33650642 [Abstract] [Full Text] [Related] Page: [Next] [New Search]